
|Articles|November 15, 2003
AMO sharpens focus on innovative technology
Author(s)Mark L. Dlugoss
A sign of an excellent company is one that capitalizes on its strengths, minimizes its weaknesses, takes advantage of its opportunities, and recognizes its threats, according to James V. Mazzo, president and chief executive officer of Advanced Medical Optics (AMO).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SparingVision completes PRODYGY trial patient dosing with SPVN06
2
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
3
PRIMA System: A major step in the battle against GA
4
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
5




























